AFAP1 and nasopharyngeal carcinoma: The lncRNA AFAP1‐AS1 competitively inhibits miR‐423‐5p expression in nasopharyngeal carcinoma cells to regulate the Rho/Rac pathway, thereby mediating the expression of FOSL2 and ultimately, promoting the distant metastasis of nasopharyngeal carcinoma cells.86